Results 181 to 190 of about 50,472 (297)

Pros: should a medically inoperable patient with a T2N0M0 non-small cell lung cancer central in the lung hilus be treated using stereotactic body radiotherapy?

, 2015
Katrina Woodford, Sashendra Senthi
openalex   +2 more sources

A retrospective comparative evaluation of rectal preparation strategies for patients undergoing stereotactic body radiotherapy for prostate cancer. [PDF]

Br J Radiol
Tran MN, Didiodato G, Lamb A, Quinn P, Kim J, Conway J, Stevens C, Yoon F, McLean J, Gladwish A.   +9 more
europepmc   +1 more source

Prognostic analysis of helical tomotherapy stereotactic body radiotherapy in multiple primary or second primary lung cancers [PDF]

Jintao Ma, Xiaohong Xu, Wenhan Huang, Yong Hu, Gang Chen, Jian He   +5 more
openalex   +1 more source

Reirradiation treatment effects in the clinic (ReTEC) proposal - proof of concept based on spinal cord dose tolerance for reirradiation with stereotactic body radiotherapy. [PDF]

J Appl Clin Med Phys
Grimm J, Mahadevan A, Obayomi-Davies O, Soltys SG, Sahgal A, Redmond KJ, Milano MT, Tomé WA, Brooks K, Dodd S, Vargo JA, Subedi G, Xue J, Ebid B, Ehret F, Rhieu BA, Fürweger C, Grimm R, Muacevic A, Moiseenko V, Kalnicki S, McLaughlin M, Kleinberg LR, Adler JR, Gibbs IC.   +24 more
europepmc   +1 more source

Results of Stereotactic Body Radiotherapy With CyberKnife-M6 for Primary and Metastatic Lung Cancer [PDF]

Gökhan Ocakoğlu, Süreyya Sarıhan, Sema Tunç, A. Kahraman, Z.K. Irem   +4 more
openalex   +1 more source

The role of stereotactic body radiotherapy in the management of hepatocellular carcinoma with macroscopic vascular invasion: a narrative review. [PDF]

ESMO Gastrointest Oncol
Gerard IJ, Glynn AM, Faye MD, Yan M, Mesci A, Kim TK, Vanner R, Dawson LA.   +7 more
europepmc   +1 more source

Stereotactic Body Radiotherapy Virtual Special Issue [PDF]

Clinical Oncology, 2016
openaire   +2 more sources

The role of stereotactic body radiotherapy in oligoprogressive breast cancer: A site-specific analysis of the prospective, phase-II RADIANT trial. [PDF]

Clin Transl Radiat Oncol
Ruicci KM, Helou J, Barry A, Ye XY, Koch CA, Croke J, Han K, Rodin D, Hahn E, Kwan JYY, Yan M, Liu FF, Lindsay P, Javor J, Bedard P, Cescon D, Kumar V, Amir E, Nadler MB, Lee R, Glicksman RM.   +20 more
europepmc   +1 more source

Tumor size as a key determinant of treatment strategy and prognosis in stereotactic body radiotherapy for pulmonary metastases: a retrospective study. [PDF]

Rep Pract Oncol Radiother
Okuma K, Kashihara T, Inaba K, Takahashi K, Sakuramachi M, Nagao A, Yoshiba A, Kobori A, Gao T, Nakamura S, Igaki H.   +10 more
europepmc   +1 more source

Prediction of health-related quality-of-life results after lung stereotactic body radiotherapy using dose-volume parameters from functional mapping on Gallium-68 perfusion PET/CT [PDF]

François Lucia, Jacques Lamour, Margaux Geier, Vincent Bourbonne, Fanny Pinot, Malik Nebbache, Frédérique Blanc-Béguin, Simon Hennebicq, Maëlle Mauguen, K. Kerleguer, Ulrike Schick, Olivier Pradier, Grégoire Le Gal, Pierre‐Yves Salaün, David Bourhis, Pierre‐Yves Le Roux   +15 more
openalex   +1 more source